NICE and PHE recommend all employers give mental health training for managers
All managers should be given the skills to support employees with mental health issues, NICE and PHE have said in new guidance.
-
Professor Gillian Leng to retire from NICE
Professor Leng has spent more than 20 years working at NICE
-
NICE recommends treatment for people with juvenile idiopathic arthritis
NICE has today (9 September 2021) published final draft guidance which recommends tofacitinib (also known as Xeljanz and made by Pfizer) as an option for treating active polyarticular juvenile arthritis and juvenile psoriatic arthritis in people 2 years and older.
-
NICE draft guidance recommends apalutamide for treating prostate cancer
NICE has today (8 September 2021) published final draft guidance which now recommends apalutamide (also called Erleada and made by Janssen) plus androgen deprivation therapy for treating prostate cancer in adults
